[go: up one dir, main page]

GB9727172D0 - Reagents specific for st2l and uses therefor - Google Patents

Reagents specific for st2l and uses therefor

Info

Publication number
GB9727172D0
GB9727172D0 GBGB9727172.0A GB9727172A GB9727172D0 GB 9727172 D0 GB9727172 D0 GB 9727172D0 GB 9727172 A GB9727172 A GB 9727172A GB 9727172 D0 GB9727172 D0 GB 9727172D0
Authority
GB
United Kingdom
Prior art keywords
st2l
uses therefor
reagents specific
reagents
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9727172.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Original Assignee
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow filed Critical University of Glasgow
Priority to GBGB9727172.0A priority Critical patent/GB9727172D0/en
Publication of GB9727172D0 publication Critical patent/GB9727172D0/en
Priority to AU19750/99A priority patent/AU1975099A/en
Priority to PCT/GB1998/003913 priority patent/WO1999034217A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9727172.0A 1997-12-24 1997-12-24 Reagents specific for st2l and uses therefor Ceased GB9727172D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9727172.0A GB9727172D0 (en) 1997-12-24 1997-12-24 Reagents specific for st2l and uses therefor
AU19750/99A AU1975099A (en) 1997-12-24 1998-12-24 Reagents specific for st2l and uses therefor
PCT/GB1998/003913 WO1999034217A1 (en) 1997-12-24 1998-12-24 Reagents specific for st2l and uses therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9727172.0A GB9727172D0 (en) 1997-12-24 1997-12-24 Reagents specific for st2l and uses therefor

Publications (1)

Publication Number Publication Date
GB9727172D0 true GB9727172D0 (en) 1998-02-25

Family

ID=10824117

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9727172.0A Ceased GB9727172D0 (en) 1997-12-24 1997-12-24 Reagents specific for st2l and uses therefor

Country Status (3)

Country Link
AU (1) AU1975099A (en)
GB (1) GB9727172D0 (en)
WO (1) WO1999034217A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323334B1 (en) 1999-09-24 2001-11-27 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding a 103 gene product and uses therefor
WO2002038794A2 (en) 2000-11-09 2002-05-16 The Brigham And Women's Hospital, Inc. Cardiovascular disease diagnostic and therapeutic targets
ES2573471T3 (en) 2002-05-09 2016-06-08 The Brigham And Women's Hospital, Inc. 1L1RL-1 as a marker of cardiovascular diseases
NZ549040A (en) * 2004-02-17 2009-07-31 Schering Corp Use for interleukin-33 (IL33) and the IL-33 receptor complex
ATE476657T1 (en) 2006-04-24 2010-08-15 Critical Care Diagnostics Inc PREDICTION OF LETHALITY AND DETECTION OF SERIOUS DISEASES
PT2021796E (en) 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnosis of cardiovascular disease
US8147817B2 (en) 2006-05-04 2012-04-03 The Brigham And Women's Hospital, Inc. IL-33 in the treatment and diagnosis of diseases and disorders
PT2827152T (en) 2008-04-18 2016-09-13 Critical Care Diagnostics Inc Predicting risk of major adverse cardiac events
HRP20160461T1 (en) * 2010-04-09 2016-06-17 Critical Care Diagnostics, Inc. SOLUBLE HUMAN ST-2 ANTIBODIES AND ESSAYS
AU2016269576B2 (en) * 2010-04-09 2018-11-08 Critical Care Diagnostics, Inc. Soluble human ST-2 antibodies and assays
AU2013204182B2 (en) * 2010-04-09 2016-09-15 Critical Care Diagnostics, Inc. Soluble human ST-2 antibodies and assays
US8785153B2 (en) 2011-02-23 2014-07-22 Hoffmann-La Roche, Inc. Antibodies against human IL33R and uses thereof
US9212227B2 (en) 2012-04-30 2015-12-15 Janssen Biotech, Inc. ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
AR091069A1 (en) 2012-05-18 2014-12-30 Amgen Inc PROTEINS OF UNION TO ANTIGEN DIRECTED AGAINST THE ST2 RECEIVER
EP3134120B1 (en) 2014-04-21 2024-01-24 The Children's Hospital of Philadelphia Compositions and methods for treating cytokine-related disorders
CN112457392B (en) * 2021-01-27 2021-04-27 天津奇云诺德生物医学有限公司 Soluble ST2 protein antigenic determinant polypeptide and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576191A (en) * 1994-06-17 1996-11-19 Immunex Corporation Cytokine that binds ST2

Also Published As

Publication number Publication date
AU1975099A (en) 1999-07-19
WO1999034217A1 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
GB2325840B (en) Heater-sensor complex
AU8121098A (en) Cell activation process and reagents therefor
GB9719044D0 (en) Assay
HUP0002986A3 (en) Fermenter
DE69806045D1 (en) Cyclische piperidinylaminomethyl-trifluoromethyl-etherderivate als substanz p-antagonisten
EP0963633A4 (en) Sample rate converter
GB9727172D0 (en) Reagents specific for st2l and uses therefor
GB9722032D0 (en) Identifying substances
GB9815224D0 (en) Assay
AU132842S (en) Distiller
IL132465A0 (en) Characterising dna
AU8682998A (en) Improvement in chemical analyses
GB9707743D0 (en) Analysis
GB9715522D0 (en) Assays
GB9721240D0 (en) Assay
GB9704162D0 (en) Assay methods and means
GB9707229D0 (en) Letter plate
GB9710623D0 (en) Carrying device
GB9727277D0 (en) Assay
GB2330295B (en) Carrying device
GB9719428D0 (en) Assay
GB9709879D0 (en) Workbench
HU9701033D0 (en) Printable odor-composition
HU9701153D0 (en) Laboratory
GB9704374D0 (en) Assay method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)